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micronization and encapsulation allow the development 
of high-quality inorganic sunscreens. The potential sys-
temic toxicity of organic sunscreens has lately primarily 
been discussed controversially in public, and several 
studies show contradictory results. Although a matter of 
debate, at present the sun protection factor (SPF) is the 
most reliable information for the consumer as a measure 
of sunscreen fi lter effi cacy. In this context additional 
tests have been introduced for the evaluation of not only 
the protective effect against erythema but also protec-
tion against UV-induced immunological and mutational 
effects. Recently, combinations of UV fi lters with agents 
active in DNA repair have been introduced in order to 
improve photoprotection. This article reviews the effi -
cacy of sunscreens in the prevention of epithelial and 
nonepithelial skin cancer, the effect on immunosuppres-
sion and the value of the SPF as well as new develop-
ments on the sunscreen market. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 Ultraviolet radiation reaching the earth’s surface con-
tains about 5% of UVB (290–320 nm) and 95% of UVA 
(320–400 nm) radiation. This UV load leads to a wide 
range of acute and chronic types of skin damage. The 
acute sunburn is mainly caused by the shorter-wavelength 
UVB fraction, while polymorphous light eruption at large 
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 Abstract 
 It is well established that sun exposure is the main cause 
for the development of skin cancer. Chronic continuous 
UV radiation is believed to induce malignant melanoma, 
whereas intermittent high-dose UV exposure contrib-
utes to the occurrence of actinic keratosis as precursor 
lesions of squamous cell carcinoma as well as basal cell 
carcinoma. Not only photocarcinogenesis but also the 
mechanisms of photoaging have recently become ap-
parent. In this respect the use of sunscreens seemed to 
prove to be more and more important and popular with-
in the last decades. However, there is still inconsistency 
about the usefulness of sunscreens. Several studies 
show that inadequate use and incomplete UV spectrum 
effi cacy may compromise protection more than previ-
ously expected. The sunscreen market is crowded by nu-
merous products. Inorganic sunscreens such as zinc ox-
ide and titanium oxide have a wide spectral range of 
activity compared to most of the organic sunscreen 
products. It is not uncommon for organic sunscreens to 
cause photocontact allergy, but their cosmetic accept-
ability is still superior to the one given by inorganic sun-
screens. Recently, modern galenic approaches such as 
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is induced by intensive UVA exposure. Chronic skin 
damage such as photoaging with wrinkling and dry ap-
pearance of the skin is due to repeated UVA exposure. 
Acute and chronic immunosuppression is not only caused 
by UVB but also UVA exposure. The most important 
chronic effect of UV irradiation is photocarcinogenesis. 
Different wavelengths cause different kinds of DNA le-
sions. UVB radiation induces the formation of thymidine 
dimers, the typical UV signature mutation. UVA light 
causes indirect oxidative stress on DNA base structures 
with the formation of reactive oxygen species. The effi -
cacy of photoprotection in sunscreens primarily is calcu-
lated based on the prevention of erythema, mainly in-
duced by UVB radiation. Yet it is still a matter of debate 
whether sunscreens can prevent harmful photoinduced 
effects other than sunburn and how this could be deter-
mined quantitatively. 
 Organic Sunscreens 
 The principle of photoprotection in organic sunscreens 
is the absorption of UV irradiation. In general, their 
chemical structure consists of aromatic compounds and 
two functional groups acting as ‘electron releasers’ and 
‘electron acceptors’. Upon UV irradiation, the molecule 
tends to delocalize the electrons to reach a higher state of 
energy. The excitation caused by absorption of UV light 
is the favored state of the molecule ( fi g. 1 ). The following 
organic sunscreens belong to the most commonly used 
groups of sunscreen compounds and present with an ab-
sorption maximum within the UVB spectrum (290–
320 nm): PABA ( p -aminobenzoic acid), octocrylene, sa-
licylates, and cinnamates. PABA was introduced as one 
of the fi rst chemical sunscreens in the 1920s. It had the 
advantage of being water resistant. However, there was 
increasing evidence that PABA can elicit photocontact 
allergies and possibly autoimmune diseases such as sys-
temic lupus erythematosus  [1] . Moreover, there were 
reports that the decomposition of PABA could produce a 
potentially carcinogenic nitrosamine degradation prod-
uct  [2] . In the 1980s, benzophenone-3 (BZ-3; oxybenzo-
ne) became the most frequently used component of sun-
screen formulations. Although reactions to PABA or 
BZ-3 are not representative for organic sunscreens any-
more, in general sunscreen products still frequently in-
duce photocontact allergic reactions  [3] . In addition, oth-
er compounds found in cosmetics for sun protection such 
as fragrances, preservatives, emulsifi ers or solvents have 
been shown to cause skin irritation, and photoallergic and 
phototoxic reactions. In contrast to these acute toxic ef-
fects of sunscreens, their chronic toxicity has not yet been 
extensively studied. One important point is the systemic 
absorption of sunscreens after topical application. It has 
been shown recently that 0.5% of the total amount of 
BZ-3, which was applied topically onto the skin, could be 
detected in the urine of human volunteers for up to 48 h 
 [4] . In experiments with rats, BZ-3 has been detected in 
the liver, kidneys, spleen, heart, muscle and testes  [5] . 
Sunscreens, including BZ-3, have also been found in hu-
man breast milk  [6] . It is still unknown whether and in 
which way the route and frequency of topical application, 
the individual capability of conjugation for the excretion 
of byproducts (e.g. in children) and the UV-induced con-
version of the parent substance into byproducts infl uence 
the systemic absorption and chronic toxicity of common 
sunscreens. In addition, the public demand for water-re-
sistant sunscreens encourages the production of more li-
pophilic substances, which could infl uence, i.e. increase, 
their dermal absorption. Another point recently studied 
is the postulated in vivo estrogenicity of UV screens  [7] . 
Six frequently used UVA and UVB sunscreens, including 
BZ-3, were administered orally (median effective dose 
1,000–1,500 mg/kg/day) to rats over a period of 4 days. 
A signifi cant increase of the uterine weight was induced 
by 3 out of the 6 sunscreens. It was, therefore, hypothe-


















 Fig. 1. PABA molecule: transfer of elec-
trons from the electron-releasing group 
(= NH 2 ) to the electron acceptor group 
(= COOH) under UV radiation [from  55 , 
with permission]. 
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tial risk for humans via bioaccumulation. But also dermal 
application could induce a signifi cant increase in the 
uterotrophic testing. This report caused a broad public 
discussion on the safety of sunscreens, some European 
countries even banned the suspected products from the 
market for a short time. Concerning this, the European 
Union (EU) cosmetics advisory committee stated that 
there are no estrogenic effects of organic sunscreen prod-
ucts allowed in the EU market. Even the estrogenicity of 
UV screens is an interesting aspect worth studying; the 
clinical relevance of these fi ndings is low because at pres-
ent the benefi t using sunscreens outweighs the risks of 
possible estrogenicity. Recent studies examined the inter-
ference of two UV fi lters, 4-methylbenzylidene camphor 
and 3-benzylidene camphor with the thyroid and sex hor-
mone system during frog metamorphosis. The results 
showed no negative effects of these UV fi lters on the sex 
ratio and thyroid system of frogs at environmental con-
centrations  [8] . Sunscreens absorbing the longer UVA 
range have been introduced late in the 1990s, when the 
contribution of UVA to photoaging and photocarcino-
genesis became apparent. Frequently used UVA sun-
blockers are among others: butyl methoxydibenzoylmeth-
ane (e.g. Parsol 1789 ® , Eusolex 9020 ® ), drometrizole 
trisiloxane (e.g. Mexoryl XL ® ) and terephthalidene dic-
amphor sulfonic acid (e.g. Mexoryl SX ® ). Micronized or-
ganic pigments such as methylene bis-benzotriazolyl tet-
ramethylbutylphenol (Tinosorb M ® ), for example, have 
been introduced as a new conceptual approach to broad-
spectrum protection. Currently, nanoparticles are used as 
delivery systems of labile organic sunscreens for the pre-
vention of photodegradation ( fi g. 3 ). An overview of some 
UV fi lters permitted in Europe is given in  table 1 . 
 The latest development is represented by UV absorb-
ers entrapped in sol-gel glass microcapsules  [9] . The ac-
tive UV fi lter is encapsulated within a silica shell of about 
1   m in diameter. The potential advantages of these ad-
vanced sunscreens are the reduction of the penetration of 
the UV fi lter, improved photostability with a lowered al-
lergy potential and avoidance of ingredient incompatibil-
ities. 
 Inorganic Sunscreens 
 Common agents for inorganic sunscreens are zinc ox-
ide (ZnO), titanium oxide (TiO 2 ), silicates and ferrum 
oxide. Disadvantages of these inorganic sunscreens are 
their visual appearance because of the solid consistency 
and white pigmentation residue on the skin. Within the 
last decades galenic preparations of improved quality be-
came available. The particles of solid inorganic sun-
screens such as zinc oxide and titanium dioxide were mi-
cronized, thus reducing the refl ection of visible light and 
giving them a more transparent appearance and allowing 
a smoother way of application  [10] . The micronization of 
the particles transforms the inorganic substances into re-
fl ectors and absorbants at the same time. Electrons of the 
metallic oxides are mobilized by absorption of UV radia-
tion, thus forming either free radicals or reactive oxygen 
species while reducing O 2 . Interestingly, it has been re-
ported that the photocatalytic activity of TiO 2  may alter 
Radiation
affected
p-Aminobenzoic acid and its esters ethylhexyl dimethyl PABA UVB
Salicylates ethylhexyl salicylate UVB
ethyl triazone UVB
homosalate UVB
Cinnamates ethylhexyl methoxycinnamate UVB
octocrylene UVB
Benzophenones BZ-3 UVB/UVA
Dibenzoylmethanes butyl methoxydibenzoylmethane UVA





Microfi ne metallic oxides titanium dioxide UVB
Table 1. A selection of sunscreen materials 
permitted for use in Europe
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cellular homoeostasis and damage cellular RNA and 
DNA  [11] . In cosmetic preparations TiO 2  is coated to 
reduce photocatalytic activity. Recent studies verify a 
suffi cient stability of coated titanium microparticles used 
in sunscreens with regard to penetration and mechanical 
abrasion simulating in-use conditions of sunscreens  [12] . 
In view of toxic effects of TiO 2  to cellular components, 
one has to say that on the one hand it does not penetrate 
the stratum corneum in viable skin. This has been con-
fi rmed by Schulz et al.  [13] , who investigated the dermal 
absorption of TiO 2  by optical and electron microscopy 
and did not detect microfi ne TiO 2  in deeper stratum cor-
neum layers or epidermis. On the other hand, it has been 
reported earlier that topical zinc ions traverse skin and 
can be found in dermis and blood  [14] . Topical applica-
tion of zinc ions protected the skin from UVA and UVB 
sunburn cell formation  [15] , by acting as free radical scav-
engers and antioxidants. Investigations on engineered hu-
man skin could demonstrate the signifi cant reduction of 
molecular photodamage after application of a sun protec-
tion factor (SPF) 28 physical sunscreen under simulated 
sunlight exposure  [16] . Comparing the two inorganic par-
ticulates currently used in sunscreens, microfi ne zinc ox-
ide and microfi ne TiO 2 , Pinnell et al.  [17] could show that 
microfi ne ZnO is more effi cient in the absorption of UV 
light, especially in the long-wave UVA spectrum, is non-
photoreactive and has a more esthetic appearance than 
microfi ne TiO 2  because of its lower refl ectance of visible 
light in this particular calculated setting ( fi g. 2 ). Neverthe-
less, the comparison depends on the particle size of the 
substances, the bigger a TiO 2  particle the more UVA pro-
tection is achieved. ZnO is currently used in sunscreens 
but not permitted as a UV fi lter in Europe. The advan-
tages of anorganic micronized refl ecting powders, in gen-
eral, are their stability, the broad-spectrum protection, 
the lack of photosensitization and their low toxicity com-
pared to chemical UV fi lters. 
 SPF, Immune Protection Factor, Mutation 
Protection Factor? 
 The SPF is a quantitative, established measure of the 
effectiveness of a sunscreen formulation. This factor is 
determined by assessing individual sensitivity to sunburn 
by solar-stimulated radiation with or without sunscreen. 
The SPF is defi ned as follows: SPF = minimal erythemal 
dose in sunscreen-protected skin divided by minimal er-
ythemal dose in non-sunscreen-protected skin. 
 In the United States sunscreens belong to the group of 
over-the-counter drugs and are supervised by the Food 
and Drug Administration (FDA). Guidelines for stan-
dardized sunscreen evaluation have been proposed by the 
FDA. They include the number of tested subjects, skin 
type, site of testing, light source, and mode of application 
 [18] . In the European countries SPF testing has been stan-
dardized by the European Cosmetic Toiletry and Perfum-
ery Association in 1994  [19] . In  table 1 a selection of UV 
fi lters permitted for use in Europe are listed. In 2000 the 
COLIPA standardized SPF test method was used as a 
basis for the development of a harmonized international 
test method between European, American, Japanese and 
South African working groups. It has to be stressed that 
the SPF, as defi ned, measures the sunscreen protection 
against erythema. Solar UV radiation (290–400 nm) 
reaching the earth surface contains no more than 5–10% 
UVB (290–320 nm) and 90–95% of UVA (320–400 nm). 
UVB is responsible for 80–90% of the sunburn. In this 
respect, the SPF measuring erythema induction is a fac-
tor measuring mainly the UVB protection of a sunscreen 
formulation. 
 Different methods for testing the UVA protection fac-
tor have been investigated, but so far no methodology for 
measuring the biological effect of UVA on the skin like 
UVA-induced photoaging comparable with the UVB ery-
thema test could be defi ned. In particular, the following 
in vivo techniques for UVA protection measurement are 
used: the persistent pigment darkening and the immedi-
ate pigment darkening method. With respect to in vitro 
methods the Australian standard testing is the only meth-
od offi cially accepted in Australia to measure UVA pro-

























 Fig. 2. The white appearance of physical sunscreens is due to their 
high scattering effi ciency of visible light. The scattering effi ciency 
for microfi ne titanium dioxide is stronger than that with microfi ne 
zinc oxide depending on the particle size [from  17 , with permis-
sion]. 
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tion factor in relation to the SPF, e.g. the Boots rating 
system  [20] . International working groups have been de-
veloping a standardized measurement for UVA protec-
tion. Currently, a new in vitro method measuring the rel-
ative UVA protection of different sun care products, the 
so-called UVA balance, has been tested and will be trans-
ferred into a DIN method soon  [21] . 
 Within the last years, problems of the SPF became ob-
vious. The reliability of SPF and corresponding testing 
methods were questioned. The SPF is a ratio based on a 
standardized but nevertheless individual test referring to 
a group of about 10–20 individuals with different skin 
types. Although it was demonstrated recently that SPF 
testing is accurate and reproducible under standardized 
conditions  [22] , the defi nite SPF in reality depends on the 
individuals’ habits and state of health. For example, the 
applied dose in lab testing is standardized with 2 mg/cm 2 . 
Observations in independent consumer groups showed 
that the amount of sunscreen applied was 0.5–1 mg/cm 2 , 
thus reducing the labelled SPF  [23] . Although the labora-
tory SPF takes photodegradation into account by measur-
ing the end point after irradiation, laboratory tests do not 
include the possible diminution of SPF by environmental 
factors and the effects of photodegradation after long-
term and repeated sun exposure. The SPF is also depen-
dent on the light source and wavelength used. Commer-
cial SPF testing is routinely performed with UV sources 
which contain a lower level of UVA compared to the 
UVA in natural sunlight. Sunscreens are believed to re-
duce long-term effects of solar exposure such as photoag-
ing and skin cancer, but the question is whether erythema 
induction as measured by the SPF is a good enough indi-
cator for UV damage such as immunosuppression, DNA 
damage, clinically overt photoaging, mutations and tu-
mor formation. 
 In this respect, the following terms have been intro-
duced: immune protection factor and mutation protec-
tion factor  [24] . The immune protection factor analogous 
to SPF defi nes the ability of a sunscreen to protect against 
immune suppression and can be calculated by comparing 
minimal immunosuppressive doses with sunscreen-pro-
tected versus nonprotected test subjects. 
 The problem in testing the immune protection factor 
is that the method is not standardized yet and depends 
on the immunological test used. The contact hypersensi-
tivity and delayed type hypersensitivity methods are two 
in vivo test modalities used to study immunosuppression. 
In contact hypersensitivity a hapten is applied directly to 
UV-irradiated skin and the degree of patch test erythema 
is measured by a refl ectance spectrometer in humans. For 
delayed type hypersensitivity, recall antigens are applied 
subcutaneously and the UV-induced suppression of the 
elicitation phase of an existing cell-mediated immune re-
sponse is documented. Another concept for measuring 
the nonerythema effects of UV radiation is the mutation 
 Fig. 3.  a ,  b Production of PLGA (poly- D , L -lactide-co-glycolide; a 
biocompatible polymer) nanoparticles as vehicles for sunscreen 
agents for the prevention of photodegradation of the sunscreen 
[from  12 , with permission]. 
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protection factor. The mutation protection factor is de-
fi ned as the ability of a sunscreen to inhibit p53 mutations 
for example as induced by UVB irradiation  [25] . The 
number of p53 mutations can be measured by allele-spe-
cifi c polymerase chain reaction and immunohistochemi-
cal staining detecting mutated p53 protein. Standardized 
techniques of calculating the mutation protection factor 
and the immune protection factor still have to be devel-
oped in the future. 
 Concerning UVA-induced photodamage a new con-
cept has been introduced recently. Photoaging studies 
with UVA recognized the direct interaction of the longer-
wavelength UVA with dermal fi broblasts. It has been 
found that mutations of mitochondrial DNA in dermal 
fi broblasts play a critical role in UVA-induced photoag-
ing  [26] . The detection of these UVA-induced deletions 
in mitochondrial DNA can be used to measure the pro-
tective effect of sunscreens against photoaging of human 
skin. 
 SPF 30 or Higher? 
 The current sunscreen market is characterized by a 
wide range of different products of varying SPFs ranging 
from less than 5 to 60. Within the last years, there was a 
tendency towards the higher SPF sunscreens of SPF 30 
and more. Recently, a SPF of 30 was claimed to be suf-
fi cient by the FDA. SPF exceeding this level will be la-
belled as 30 plus. The question remains if there is a need 
for sunscreens with a SPF higher than 30. A number of 
facts do speak for a further development and use of high 
SPF. One fact, which has already been mentioned earlier, 
is that the application modality differs in testing methods 
and in consumer habits and the applied dose of sun-
screens does not exceed 1 mg/cm 2  in reality. This is half 
of the standardized testing amount of 2 mg/cm 2 . In this 
way, the application of high SPF sunscreens may still 
reach a higher sun protection despite a wrong application 
technique than a low SPF sunscreen. Another point of 
discussion is that in commercial sunscreen testing facili-
ties, subjects of the Fitzpatrick skin type 1 and 2 are pre-
ferred, because of their quick erythema induction under 
UV light. Interestingly, in persons of higher skin types the 
SPF decreases  [27] . In this way, the labelled SPF will be 
lower than labelled in the normal population with differ-
ent skin types. This clearly speaks for the use of higher 
SPF sunscreens. Additionally, it has already been men-
tioned that although testing UV sources refl ect standard-
ized FDA and COLIPA guidelines, they still do not nec-
essarily need a UVA fraction as high as found in natural 
UV light ( fi g. 4 ). As UVA light does also induce erythema 
a UVA-reduced source will produce a higher SPF  [28] . In 
animal models, it has been shown that already suberythe-
mal doses are suffi cient to induce photocarcinogenesis 
with DNA damage and immune suppression. In this re-
spect, high SPF sunscreens could possibly offer a better 
protection against suberythemal UV damage than lower 
SPF sunscreens. 
 Concomitant factors responsible for the reduction of 
the labelled SPF are daily in-use conditions such as sweat-
ing, rubbing, abrasion, water immersion and photodegra-
dation of the products, for example. A main indication 
for the development of high SPF sunscreens anyhow re-
mains with respect to the protection of high-risk patients 
with photosensitive disorders such as lupus erythemato-
sus or porphyria. It could be shown that preparations con-
taining the extremely high formulation of 50% TiO 2  were 
more suffi cient in reducing light transmission and in cell 
protection of photosensitized skin compared to usual 
sunscreens  [29] . Interestingly, photosensitized patients 
very often feel no suffi cient benefi t from sunscreen use. 
Studies could show that not only the wrong application 
technique  [30] as mentioned before but also the use of 
common narrow-band sunscreens is one reason for inad-































 Fig. 4. Comparison of spectral irradiances of natural sunlight, Ori-
el 1000 W solar simulator and a commonly used commercial solar 
simulator: the two UV sources have similar UVB (290–320 nm) 
irradiances, but less UVA (340–400 nm) production than natural 
sunlight [from  56 , with permission]. 
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sitivity disorders are caused by UVA, only broad-spec-
trum sunscreens can offer ideal protection. 
 To summarize, despite its limitations discussed above 
the SPF is the most reliable key information for the con-
sumer of sun care products at present. 
 Photocarcinogenesis 
 Sunscreens and Nonmelanoma Skin Cancer 
 The infl uence of sunscreen use on the incidence of ep-
ithelial tumors has been documented in several human 
epidemiological studies. It has been shown that repeated 
application of sunscreen can moderately, yet signifi cantly 
reduce the development of precursor lesions such as solar 
keratoses in comparison to placebo use  [31] . Naylor et al. 
 [32], moreover, demonstrated in a controlled trial with a 
2-year follow-up that regular use of a sunscreen can sig-
nifi cantly reduce cutaneous carcinoma by suppression of 
precancerous lesions. Darlington et al.  [33] could show a 
signifi cant reduction of solar keratoses in sunscreen users, 
while a   -carotene supplementation performed perorally 
had no infl uence on the occurrence of actinic keratoses. 
A large randomized trial with a 4.5-year follow-up phase 
by Green et al.  [34] showed the preventive effect of con-
sistent sunscreen use by adults on the incidence of squa-
mous cell carcinoma. Additionally, a study from 1986 
demonstrated the protective effect of sunscreen in child-
hood as regards nonmelanoma skin cancer  [35] . Despite 
these corresponding data, there exists a group of reports 
showing exactly the opposite. Kricker et al.  [36], for ex-
ample, observed an elevated incidence of basal cell carci-
noma in sunscreen users. Perhaps the latter type of tumor 
must be considered separately from the other frequent 
type of nonmelanoma skin cancer. 
 Sunscreens and Melanoma 
 Several studies have demonstrated the protective ef-
fects of sunscreen use in precancerous and cancerous skin 
lesions. However, the preventive effect of photoprotec-
tion on melanoma is still a matter of discussion. A variety 
of studies have shown confl icting results. Recently, an 
epidemiological study performed by Autier et al.  [37] pre-
sented an increase in the melanoma incidence with re-
peated use of sunscreen. This fi nding is supported by an 
observed increase of the number of nevi in European chil-
dren despite sunscreen use. In contrast to that, Gallagher 
et al.  [38] documented a reduced number of nevi in fair-
skinned children under sunscreen-induced photoprotec-
tion. It still remains unclear which wavelength is respon-
sible for melanoma induction. UVB is known to cause 
direct DNA damage with the formation of thymidine di-
mers (mostly C-T transversions, called UV signature mu-
tation). A defective nucleotide excision repair system, for 
example the UVB mutation of the p53 suppressor gene, 
could contribute to the development of neoplasia such as 
melanoma. The more indirect UVA-induced oxidative 
DNA damage could play a crucial role in the initiation of 
melanoma. Additionally, the UV-induced suppression of 
immunity would allow p53-mutated cells to proliferate 
and expand. Within recent years, the contribution of 
UVA-induced immune suppression to photocarcinogen-
esis through an oxidative pathway became a point of in-
terest. So far, it has to be stated that UVA radiation acts 
as a tumor promotor, but not initiator. Similar to UVB, 
UVA is capable to induce specifi c mutations in oncogenes 
(mostly T-G transitions in the p53 gene), but the effects 
are less dramatic than those induced by UVB. As far as 
it appears today, not only UVB but also UVA could con-
tribute to the development of melanoma  [39] ( fi g. 5 ). In 
this respect, the use of broad-spectrum sunscreens seems 
to be an important issue in the prevention of melanoma 
induction. Broad-spectrum sunscreens providing high 
UVA protection have become popular only within the last 
decade. This might be one reason for the studies report-
ing an increased melanoma incidence despite sunscreen 
application. Another point often mentioned is the fact 
that the higher the SPF, the longer the recreational sun 







 Fig. 5. Proposed model of photocarcinogenesis. 
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 New Developments 
 The usefulness of sunscreens as discussed above is still 
not ideal because of the inadequate use, incomplete spec-
tral range of activity and potential toxicity. In this respect, 
a variety of supplements have been studied recently in 
order to improve photoprotection. The following sub-
stances added to sunscreens failed to increase the protec-
tive effect. Dietary   -carotene known as a free radical 
scavenger did not improve the effect of sunscreen use on 
the development of skin cancer in humans  [33, 34] . In 
animal experiments,   -carotene could not overcome 
UVB-induced immunosuppression measured by contact 
hypersensitivity testing  [40] . 
 Another animal model-based trial investigated the 
protective effect of the chemically induced epidermal me-
lanogenesis with furocoumarin. This epidermal tanning 
did not protect against photocarcinogenesis in mice  [41] . 
Synthetic suntan induced by self-tanning products con-
taining dihydroxyacetone (DHA) was believed to have no 
protection against photoinduced skin damage  [42] . Re-
cent studies reported on a photoprotective effect of DHA 
against UVB and the ability to delay photocarcinogenesis 
in hairless mice  [43] . The combination of an insect repel-
lent such as diethylmethylbenzamide (DEET) with sun-
screens reduces the SPF of the sunscreens due to its sol-
vent action and is not advisable  [44] . Positive effects of 
reducing photodamage have been observed with plant 
extracts functioning as antioxidants. The photoaging pro-
cess and photocarcinogenesis in particular is partly caused 
by reactive oxygen species. The topical application of 
plant oligo- or polysaccharides has been shown to have 
antioxidant effects, e.g., extracts of aloe vera or tamarind 
applied topically inhibited the UVB-induced immuno-
suppression and reduced IL-10 production in keratino-
cytes. Natural fl avonoids such as green or black tea poly-
phenols  [45, 46] , epigenin  [47] and silymarin (milk this-
tle) reduced UVB-induced erythema, tumorigenesis and 
immunosuppression in mice  [48] . The two antioxidant 
vitamins C and E are promising supplements in sun-
screens. Ascorbic acid prevented the secretion of proin-
fl ammatory cytokines by UVA, UVB-induced DNA 
damage and UV-induced immunosuppression in several 
studies  [49] . -Tocopherol reduced UVB-induced erythe-
ma, DNA damage and restored immune responses  [50] . 
N-Acetylcysteine is known as another antioxidant and 
has been investigated with respect to its photoprotective 
effects. In mice experiments it was capable to repair UV-
induced DNA damage in keratinocytes  [51] . Another 
scavenger of free radicals is the hydroxypropyl-  -cyclo-
dextrin (HP-  -CD), which has shown its ability to effec-
tively scavenge free radicals produced by the sunscreen 
agent butyl methoxydibenzoylmethane  [52] . A stable trap 
radical was used for coupling of free radicals which were 
generated during irradiation of the sunscreen with and 
without HP-  -CD. A new topical mechanism is the direct 
application of DNA repair enzymes after photoinduced 
DNA damage with dimer formation. The dimer-specifi c 
photolyase was encapsulated into liposomes and topical-
ly administered immediately after UVB irradiation as re-
cently published by Krutman  [53] . UVB radiation-in-
duced dimers were reduced by 40–45%. Accordingly, the 
dimer repair prevented the UVB-induced immune sup-
pression. In patients with xeroderma pigmentosum the 
daily application of liposomal DNA repair enzymes for 1 
year could diminish the rate of new actinic keratoses and 
basal cell carcinoma  [54] . In contrast to conventional sun-
screens, which offer only prophylactic protection, the 
above-mentioned approaches could restore damage, 
which has already occurred, thus giving the opportunity 
of combining protection with repair. Yet the long-term 
effects or best application mode have not been investi-
gated to the needed extent so far. 
 Final Remarks 
 Evidence is accumulating that various skin cancers 
and photoaging are not only caused by one type of UV 
light but by the whole spectrum of sun rays. In this respect 
sunscreens with UVA protection abilities have recently 
become the center of interest. Mainly inorganic sun-
screens experience a revival as they provide full-spectrum 
protection and so prevent photocarcinogenesis. The two 
mainly used inorganic substances TiO 2  and ZnO offer 
excellent UV protection and due to the modern cosmetic 
formulations such as the nanoparticle encapsulation of 
sunscreens, their cosmetic appearance has much im-
proved. The main advantage of inorganic sunscreens ver-
sus organic screens is their low allergenic potential. Or-
ganic sunscreens are known to induce allergic contact der-
matitis and photoallergic dermatitis. Although the UVA 
protection factor is often not defi ned exactly, an adequate 
photoprotection can only be achieved with broad-spec-
trum sunscreens, including UVA. High SPF should be 
preferred, as the common in-use conditions reduce the 
labelled SPF. In view of recently discussed systemic ef-
fects of sunscreens, it seems advisable to use inorganic 
sunscreens particularly in children or to prevent absorp-
tion by entrapment with glass capsules. Nevertheless, for 
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full photoprotection sunscreens should be combined with 
other protection methods such as reduction of sun ex-
posure, avoidance of sun, protection clothes and sun 
glasses. 
 In conclusion, despite controversial results concerning 
the benefi cial effects of sunscreens and their effi cacy in 
the prevention of skin neoplasias, including melanoma, 
regular use of sunscreens should be recommended. 
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